Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study
(Q51550717)
scientific article published in May 1999
scientific article published in May 1999
Language:
Current Data About
Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study
other details
description | scientific article published in May 1999 |
External Links
(P356) |
10.1046/J.1463-1326.1999.00020.X
|
(P698) |
11220295
|